Cargando…

A Genome-First Approach to Estimate Prevalence of Germline Pathogenic Variants and Risk of Pancreatic Cancer in Select Cancer Susceptibility Genes

SIMPLE SUMMARY: Prevalence and cancer risk estimates derived from the evaluation of affected individuals in the clinic are subject to ascertainment bias. This limitation can be mitigated using a genome-first approach in which genotypic data is analyzed before knowing a patient’s phenotype. Our study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Astiazaran-Symonds, Esteban, Kim, Jung, Haley, Jeremy S., Kim, Sun Young, Rao, H. Shanker, Genetics Center, Regeneron, Carey, David J., Stewart, Douglas R., Goldstein, Alisa M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265005/ https://www.ncbi.nlm.nih.gov/pubmed/35805029 http://dx.doi.org/10.3390/cancers14133257

Ejemplares similares

A systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancer
por: Astiazaran-Symonds, Esteban, et al.
Publicado: (2021)

Polygenic scores for low lung function and the future risk of adverse health outcomes
por: Zaigham, Suneela, et al.
Publicado: (2022)

Associations of genome-wide and regional autozygosity with 96 complex traits in old order Amish
por: Lynch, Megan T., et al.
Publicado: (2023)

Genome-first approach of the prevalence and cancer phenotypes of pathogenic or likely pathogenic germline TP53 variants
por: de Andrade, Kelvin C., et al.
Publicado: (2023)

The prevalence of germline DICER1 pathogenic variation in cancer populations
por: Kim, Jung, et al.
Publicado: (2019)

Visualization and Quantification of the Association Between Breast Cancer and Cholesterol in the All of Us Research Program
por: Feng, Jianglin, et al.
Publicado: (2023)

Predicted Chemotherapy Benefit for Breast Cancer Patients With Germline Pathogenic Variants in Cancer Susceptibility Genes
por: Kurian, Allison W, et al.
Publicado: (2020)

Prevalence of germline pathogenic variants in 22 cancer susceptibility genes in Swedish pediatric cancer patients
por: von Stedingk, Kristoffer, et al.
Publicado: (2021)

Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes
por: Mavaddat, Nasim, et al.
Publicado: (2022)

Targeted Sequencing of Germline Breast Cancer Susceptibility Genes for Discovering Pathogenic/Likely Pathogenic Variants in the Jakarta Population
por: Panigoro, Sonar Soni, et al.
Publicado: (2022)

Frequency of pathogenic germline variants in cancer susceptibility genes in 1336 renal cell carcinoma cases
por: Yngvadottir, Bryndis, et al.
Publicado: (2022)

Genome‐wide association analysis of serum alanine and aspartate aminotransferase, and the modifying effects of BMI in 388k European individuals
por: Gao, Chuan, et al.
Publicado: (2021)

Germline pathogenic variants in unselected Korean men with prostate cancer
por: So, Min-Kyung, et al.
Publicado: (2022)

Prevalence of Germline Pathogenic Variants in Cancer Predisposing Genes in Czech and Belgian Pancreatic Cancer Patients
por: Wieme, Greet, et al.
Publicado: (2021)

Germline breast cancer susceptibility genes, tumor characteristics, and survival
por: Ho, Peh Joo, et al.
Publicado: (2021)

NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects
por: Belhadj, Sami, et al.
Publicado: (2023)

Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening
por: Cremin, Carol, et al.
Publicado: (2020)

Germline Cancer Susceptibility Gene Testing in Unselected Patients with Hepatobiliary Cancers: A Multi-Center Prospective Study
por: Uson Junior, Pedro LS, et al.
Publicado: (2022)

Germline breast cancer susceptibility gene mutations and breast cancer outcomes
por: Wang, Yong Alison, et al.
Publicado: (2018)

The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility
por: Liu, Mengyuan, et al.
Publicado: (2020)

Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing Study
por: Uson, Pedro L. S., et al.
Publicado: (2021)

Rare Germline Variants in Chordoma-Related Genes and Chordoma Susceptibility
por: Yepes, Sally, et al.
Publicado: (2021)

Rate of Pathogenic Germline Variants in Patients With Lung Cancer
por: Sorscher, Steven, et al.
Publicado: (2023)

An integrated somatic and germline approach to aid interpretation of germline variants of uncertain significance in cancer susceptibility genes
por: Schwartz, Alison, et al.
Publicado: (2022)

Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A
por: Llach, Joan, et al.
Publicado: (2023)

Germline pathogenic variants in 786 neuroblastoma patients
por: Kim, Jung, et al.
Publicado: (2023)

Unusual phenotypes in patients with a pathogenic germline variant in DICER1
por: Venger, Kateryna, et al.
Publicado: (2021)

Prevalence of Germline Pathogenic and Likely Pathogenic Variants in Patients With Second Breast Cancers
por: Yao K, Katharine A, et al.
Publicado: (2020)

Prevalence and Risk Factors of Germline Pathogenic Variants in Pancreatic Ductal Adenocarcinoma
por: Ryu, Kum Hei, et al.
Publicado: (2023)

Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants
por: Murali, Krithika, et al.
Publicado: (2021)

Evaluation of inherited germline mutations in cancer susceptibility genes among pancreatic cancer patients: a single-center study
por: Tavano, Francesca, et al.
Publicado: (2023)

Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes
por: Mizukami, Keijiro, et al.
Publicado: (2020)

Germline Pathogenic Variants Identified by Targeted Next-Generation Sequencing of Susceptibility Genes in Pheochromocytoma and Paraganglioma
por: Yalcintepe, Sinem, et al.
Publicado: (2021)

Correction to: Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants
por: Murali, Krithika, et al.
Publicado: (2021)

Germline pathogenic variants associated with ovarian cancer: A historical overview
por: Johansen, Emma Lund, et al.
Publicado: (2022)

Genetic and genomic analysis modeling of germline c-MYC overexpression and cancer susceptibility
por: Solé, Xavier, et al.
Publicado: (2008)

Mutation spectrum of germline cancer susceptibility genes among unselected Chinese colorectal cancer patients
por: Gong, Rui, et al.
Publicado: (2019)

Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer
por: Pietzak, Eugene J., et al.
Publicado: (2022)

Using whole-exome sequencing and protein interaction networks to prioritize candidate genes for germline cutaneous melanoma susceptibility
por: Yepes, Sally, et al.
Publicado: (2020)

Synchronous Onset of Breast and Pancreatic Cancers: Results of Germline and Somatic Genetic Analysis
por: Castro, Michael, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_46pd4t7teo49d5egdj4obnfrj6